Intestinal Current Measurements Detect Activation of Mutant CFTR in Patients with Cystic Fibrosis with the G551D Mutation Treated with Ivacaftor
- 15 November 2015
- journal article
- letter
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 192 (10) , 1252-1255
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2014
- WS23.3 ICM is sensitive to detect potentiation of CFTR-mediated Cl− secretion in patients with cystic fibrosis and the G551D mutation treated with ivacaftorJournal of Cystic Fibrosis, 2014
- Optimizing Nasal Potential Difference Analysis for CFTR Modulator Development: Assessment of Ivacaftor in CF Subjects with the G551D-CFTR MutationPLOS ONE, 2013
- Change in Sweat Chloride as a Clinical End Point in Cystic Fibrosis Clinical TrialsChest, 2013
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutationNew England Journal of Medicine, 2011
- The K+ Channel Opener 1-EBIO Potentiates Residual Function of Mutant CFTR in Rectal Biopsies from Cystic Fibrosis PatientsPLOS ONE, 2011
- Diversity of the basic defect of homozygous CFTR mutation genotypes in humansJournal of Medical Genetics, 2008
- CFTR Cl− channel function in native human colon correlates with the genotype and phenotype in cystic fibrosisGastroenterology, 2004
- Assessment of CFTR function in rectal biopsies for the diagnosis of cystic fibrosisJournal of Cystic Fibrosis, 2004
- Determinants of mild clinical symptoms in cystic fibrosis patients. Residual chloride secretion measured in rectal biopsies in relation to the genotype.Journal of Clinical Investigation, 1994